Evidence is limited to animal or in-vitro work. No human pharmacokinetics. Any human dose in circulation is extrapolated, and extrapolation across species routinely fails.
No validated pharmacokinetic half-life located in an allowed primary source. 24-amino-acid peptide encoded in the mitochondrial 16S rRNA region.
No established human dose. Animal studies use the potent HNG analog on a body-weight basis (e.g., twice-weekly injections in mice); not standardized. Kept qualitative per instructions.
Rodent and cell-model studies (neuroprotection, metabolic healthspan) and mechanistic work; no controlled human efficacy or PK data in allowed sources.
No human safety data. Preclinical only; safety in humans unestablished. Not for clinical dosing decisions.